Galderma and PatientFi—the company behind aesthetics membership platform PRIVI—announced a first-of-its-kind offering to a convenient, monthly membership that expands patient access Galderma’s portfolio of innovative injectables, including the most comprehensive portfolio of hyaluronic acid (HA) dermal fillers, a one-of-a kind poly-L-lactic acid injectable and a natural, long-lasting and fast-acting neuromodulator. As a result of the collaboration, practices that choose Galderma’s portfolio of aesthetics treatments will achieve increased revenue through repeat visits, greater patient satisfaction, and long-term loyalty.
Cost is the biggest barrier to aesthetics treatment, and this collaboration helps mitigates patient cost concerns while deepening injectors’ ability to build loyalty in an increasingly crowded market. PRIVI seamlessly connects with ASPIRE Galderma Rewards, allowing patients to earn points/rewards while helping practices boost retention.
The collaboration makes injectable treatments more accessible, unlocks pent-up demand for aesthetics treatment and provides more options for individuals seeking consistent results.